Cases | Joins | Joinpoint Year | AAPC (95% CI) | P-Value | |
---|---|---|---|---|---|
HPV-related CC | |||||
Anogenital warts | – | – | |||
Men | 420 | 0 | – | 19.5 (13.9–25.3) | < 0.0001 |
Women | 51 | 0 | – | 19.5 (13.9–25.3) | < 0.0001 |
Black | 312 | 0 | – | 20.4 (15.5–25.5) | < 0.0001 |
White | 160 | 0 | – | 20.4 (15.5–25.5) | < 0.0001 |
Anal HSIL (men only) | 71 | 0 | – | ||
Black | 38 | 0 | – | 25.6 (9.7–43.9) | 0.0040 |
White | 33 | 0 | – | 23.1 (−0.2–52.0) | 0.052 |
Anal cancer (men only) | 43 | 0 | – | 5.6 (−4.9, 17.2) | 0.29 |
Black | 18 | 0 | – | – | – |
White | 24 | 0 | – | – | – |
Cervical HSIL | 2 | 2013,2016 | 22.5 (−4.5–57.1) | 0.11 | |
Black | 54 | 2 | 2013,2016 | ||
White | 25 | 2 | 2013,2016 | ||
– | 2006–2013* | 29.8 (11.6–50.9) | 0.002 | ||
– | 2013–2016* | −38.3 (− 73.9–45.7) | 0.25 | ||
– | 2016–2018* | 179.6 (20.9–546.7) | 0.020 | ||
Cervical cancer | 12 | 2 | 2012, 2016 | 15.9 (−9.7–48.7) | 0.2 |
Black | 6 | 2 | 2012, 2016 | – | – |
White | 6 | 2 | 2012, 2016 | – | – |
– | 2006–2012* | 17.1 (−2.4–40.6) | 0.084 | ||
– | 2012–2016* | −26.4 (− 58.7–31.3 | 0.27 | ||
– | 2016–2018* | 177.5 (1.3–660.0) | < 0.0001 |